SEC Form 4 · accession 0001628280-18-012512
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Ackerman
Director
Period of report
Oct 12, 2018
Accepted (ET)
Oct 12, 2018 · 2:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 12, 2018 | M | 100,000 | $2.10 | A | 1,121,731 | D | |
| Common StockF1 | Oct 12, 2018 | F | 12,021 | $17.47 | D | 1,109,710 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF2 | $2.10 | Oct 12, 2018 | M | 100,000 | D | — | Oct 25, 2025 | Common Stock | 100,000 | 0 | D |
Explanation of responses
- F1Represents a "net exercise" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on September 30, 2018.
- F2The options were immediately exercisable upon grant on July 21, 2016.